Jun Cao

发表

A phase II trial of biweekly vinorelbine and oxaliplatin in second- or third-line metastatic triple-negative breast cancer

Z. Shao, Jian Zhang, Leiping Wang, 2015, Cancer biology & therapy.

Multicenter phase II study of Apatinib in non-triple-negative metastatic breast cancer

Wen-Wei Hu, Changping Wu, L. Cai, 2014, BMC Cancer.

Whether low-dose metronomic oral cyclophosphamide improves the response to docetaxel in first-line treatment of non-triple-negative metastatic breast cancer

S. Zhang, Z. Shao, Jian Zhang, 2017, Oncotarget.

Hypothyroidism as a potential biomarker of efficacy of famitinib, a novel VEGFR-2 inhibitor in metastatic breast cancer

Jian Zhang, Leiping Wang, Zhonghua Wang, 2014, Cancer Chemotherapy and Pharmacology.

OP0001 Hypothyroidism as a potential biomarker of efficacy of famitinib, a novel VEGFR2 inhibitor in metastatic breast cancer

Jian Zhang, Leiping Wang, Zhonghua Wang, 2014 .

Bevacizumab in Combination with Modified FOLFOX6 in Heavily Pretreated Patients with HER2/Neu-Negative Metastatic Breast Cancer: A Phase II Clinical Trial

S. Zhang, J. Ragaz, Si Sun, 2015, PloS one.

Epirubicin combined with oxaliplatin and 5-day continuous infusion of 5-fluorouracil as a first-line treatment for metastatic gastric cancer: treatment outcomes and analysis of prognostic factors

W. Peng, Xiao-dong Zhu, Si Sun, 2014, Journal of Cancer Research and Clinical Oncology.

Jian Zhang, Leiping Wang, Xichun Hu, 2021 .

Dalpiciclib Combined With Pyrotinib and Letrozole in Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer (LORDSHIPS): A Phase Ib Study

W. Yao, Ting Li, Jian Zhang, 2022, Frontiers in Oncology.

DNA damage response inhibitors: An avenue for TNBC treatment.

Ting Li, Xichun Hu, Jun Cao, 2021, Biochimica et biophysica acta. Reviews on cancer.

Overall survival of cancer patients with serum lactate dehydrogenase greater than 1000 IU/L

Lin Guo, Xiang Gao, Jian Zhang, 2016, Tumor Biology.

Continuous infusion of Endostar combined with chemotherapy in patients with advanced or recurrent mucosal melanoma: A real-world cohort study.

Xichun Hu, Jun Cao, Y. Kong, 2021, Journal of Clinical Oncology.

Phase II Study of Pseudomonas aeruginosa-Mannose-Sensitive Hemagglutinin in Combination with Capecitabine for Her-2–Negative Metastatic Breast Cancer Pretreated with Anthracycline and Taxane

Z. Shao, Jian Zhang, Leiping Wang, 2015, PloS one.

Apatinib plus vinorelbine versus vinorelbine for metastatic triple-negative breast cancer who failed first/second-line treatment: the NAN trial

Jian Zhang, Leiping Wang, Xichun Hu, 2022, npj Breast Cancer.

Phase II study of chidamide in combination with cisplatin in patients with metastatic triple-negative breast cancer.

Ting Li, Jian Zhang, Leiping Wang, 2021, Annals of palliative medicine.

Phase 1b clinical trial of pucotenlimab (HX008), a novel anti-PD-1 monoclonal antibody, combined with gemcitabine and cisplatin in the first-line treatment of metastatic triple-negative breast cancer

Jian Zhang, Leiping Wang, Xichun Hu, 2022, Frontiers in Oncology.

Cisplatin given at three divided doses for three consecutive days in metastatic breast cancer: an alternative schedule for one full dose with comparable efficacy but less CINV and hypomagnesaemia

Bao-ying Yuan, Ting Li, Yizi Jin, 2019, Breast Cancer Research and Treatment.

Incidence of peripheral neuropathy associated with eribulin mesylate versus vinorelbine in patients with metastatic breast cancer: sub-group analysis of a randomized phase III study

Jian Zhang, Xichun Hu, Biyun Wang, 2019, Supportive Care in Cancer.

Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study

L. Cai, P. Shen, Yue-Yin Pan, 2018, Breast Cancer Research and Treatment.

Malic enzyme 1 may be a novel target of breast cancer metastasis

Xichun Hu, Jun Cao, Shu-chen Lin, 2019 .

Temporal Heterogeneity of HER2 Expression and Spatial Heterogeneity of 18F-FDG Uptake Predicts Treatment Outcome of Pyrotinib in Patients with HER2-Positive Metastatic Breast Cancer

Jian Zhang, Leiping Wang, Xichun Hu, 2022, Cancers.

Real-World Data of Pyrotinib-Based Therapy in Metastatic HER2-Positive Breast Cancer: Promising Efficacy in Lapatinib-Treated Patients and in Brain Metastasis

S. Zhang, Jian Zhang, Leiping Wang, 2020, Cancer research and treatment : official journal of Korean Cancer Association.

Comparison of two regimens of weekly paclitaxel plus gemcitabine in patients with metastatic breast cancer: propensity score–matched analysis of real-world data

Jian Zhang, Leiping Wang, Xichun Hu, 2022, Therapeutic advances in drug safety.

Large-scale isolation and antitumor mechanism evaluation of compounds from the traditional Chinese medicine Cordyceps Militaris.

Guixue Wang, Yuqian Wu, Jun Cao, 2020, European journal of medicinal chemistry.

Caveolin-1 expression predicts efficacy of weekly nab-paclitaxel plus gemcitabine for metastatic breast cancer in the phase II clinical trial

Jian Zhang, Leiping Wang, Zhonghua Wang, 2018, BMC Cancer.

Efficacy and safety of mitoxantrone hydrochloride liposome injection in Chinese patients with advanced breast cancer: a randomized, open-label, active-controlled, single-center, phase II clinical trial

Ting Li, Jian Zhang, Leiping Wang, 2021, Investigational New Drugs.

Depletion of SENP1 suppresses the proliferation and invasion of triple-negative breast cancer cells.

Jian Zhang, Leiping Wang, Zhonghua Wang, 2016, Oncology reports.

Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer

Z. Shao, Jian Zhang, Leiping Wang, 2018, BMC Cancer.

Functional consequences of a rare missense BARD1 c.403G>A germline mutation identified in a triple-negative breast cancer patient

Leming Shi, T. Qing, Yuanting Zheng, 2021, Breast cancer research : BCR.

Exosomal annexin A6 induces gemcitabine resistance by inhibiting ubiquitination and degradation of EGFR in triple-negative breast cancer

Ting Li, Jian Zhang, Leiping Wang, 2021, Cell Death & Disease.

The human chemokine receptor CCRL2 suppresses chemotaxis and invasion by blocking CCL2-induced phosphorylation of p38 MAPK in human breast cancer cells

Jun Cao, Jian Zhang, Z. Ou, 2015, Medical Oncology.

GSTT1, GSTP1, and GSTM1 genetic variants are associated with survival in previously untreated metastatic breast cancer

S. Zhang, Jian Zhang, Leiping Wang, 2017, Oncotarget.

Landscape of DNA damage response gene alterations in breast cancer: A comprehensive investigation

Ting Li, Jian Zhang, Leiping Wang, 2023, Cancer.

Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer

Z. Shao, Jian Zhang, Leiping Wang, 2018, BMC Cancer.

Clinical Outcomes of 130 Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Treated with Palbociclib plus Endocrine Therapy and Subsequent Therapy: A Real-World Single-Center Retrospective Study in China

Ting Li, Jian Zhang, Leiping Wang, 2020, Medical science monitor : international medical journal of experimental and clinical research.

Characterizations of Cancer Gene Mutations in Chinese Metastatic Breast Cancer Patients

Ting Li, Jian Zhang, Leiping Wang, 2020, Frontiers in Oncology.

Rh-endostatin combined with chemotherapy in patients with advanced or recurrent mucosal melanoma: retrospective analysis of real-world data

Jun Cao, Y. Kong, Xin Liu, 2021, Investigational New Drugs.

Optimal duration of prior endocrine therapy predicts the efficacy of Fulvestrant in a real‐world study for patients with hormone receptor‐positive and HER2‐negative advanced breast cancer

Jian Zhang, Leiping Wang, Xichun Hu, 2020, Cancer medicine.

An integrated bioinformatics analysis to investigate the targets of miR-133a-1 in breast cancer

Ting Li, Jian Zhang, Leiping Wang, 2021, Translational cancer research.

Phase II trail of nab-paclitaxel in metastatic breast cancer patients with visceral metastases

Ting Li, Jian Zhang, Leiping Wang, 2021, BMC Cancer.

Apatinib for metastatic breast cancer in non-clinical trial setting: Satisfying efficacy regardless of previous anti-angiogenic treatment

Zheng Wu, Jian Zhang, Leiping Wang, 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

A randomized phase II study of aromatase inhibitors plus metformin in pre-treated postmenopausal patients with hormone receptor positive metastatic breast cancer

S. Zhang, Ting Li, Jian Zhang, 2017, Oncotarget.

An explorative analysis of the prognostic value of lactate dehydrogenase for survival and the chemotherapeutic response in patients with advanced triple-negative breast cancer

Jian Zhang, Leiping Wang, Zhonghua Wang, 2018, Oncotarget.

Neutropenia predicts better prognosis in patients with metastatic gastric cancer on a combined epirubicin, oxaliplatin and 5-fluorouracil regimen

Si Sun, W. Peng, Jun Cao, 2015, Oncotarget.

miR-331-3p Suppresses Cell Proliferation in TNBC Cells by Downregulating NRP2

Ming-chuan Zhao, Leiping Wang, Xichun Hu, 2020, Technology in cancer research & treatment.

Cisplatin shows greater efficacy than gemcitabine when combined with nab-paclitaxel in metastatic triple-negative breast cancer

Jian Zhang, Leiping Wang, Xichun Hu, 2019, Scientific Reports.

Chemotherapy of metastatic triple negative breast cancer: Experience of using platinum-based chemotherapy

S. Zhang, Ting Li, M. Fan, 2015, Oncotarget.